Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 536.00
Bid: 534.00
Ask: 538.00
Change: -4.00 (-0.74%)
Spread: 4.00 (0.749%)
Open: 550.00
High: 550.00
Low: 532.00
Prev. Close: 540.00
BMY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bloomsbury Acquires Oberon Books

10 Dec 2019 10:45

RNS Number : 3616W
Bloomsbury Publishing PLC
10 December 2019
 

10 December 2019

 

BLOOMSBURY PUBLISHING Plc

("Bloomsbury")

 

BLOOMSBURY ACQUIRES OBERON BOOKS

 

 

Bloomsbury Publishing Plc ("Bloomsbury") announces that it has today completed the acquisition of the entire issued share capital of Oberon Books Limited ("Oberon" or the "Acquisition"), the London-based drama publisher. The consideration was £1.2 million, all of which was satisfied in cash at completion. The business will operate within Bloomsbury's Academic & Professional division. Oberon generated £1.0 million* of revenue in the year ended 31 December 2018. There are opportunities for profit enhancements following the integration of the business into Bloomsbury. The Acquisition is expected to break even in its first year, before reorganisation and acquisition costs, then be earnings enhancing thereafter. It will contribute approximately £0.1 million of revenue to Bloomsbury in the year ending 28 February 2020. (*Unaudited)

 

This acquisition comes as Bloomsbury celebrates 60 years of Methuen Drama's Modern Plays, and the crowning of The Arden Shakespeare Third series, with the final play, Measure for Measure, publishing in January. The Oberon programme aligns perfectly with Bloomsbury's existing publishing, whilst strengthening its offerings in contemporary and cutting-edge theatre. With the combined lists of Oberon, Methuen Drama and The Arden Shakespeare, Bloomsbury is now the leading publisher in drama and the performing arts.

 

Jonathan Glasspool, Managing Director of Bloomsbury's Academic & Professional Division said:

"We are delighted to become owners of the prestigious Oberon list. The Oberon programme aligns very well with our existing publishing within Methuen Drama. The Oberon list strengthens our offerings in contemporary theatre. With the combined lists of Oberon, Methuen Drama and The Arden Shakespeare, Bloomsbury is looking forward to developing and diversifying its position as the world's leading international publisher in drama and the performing arts."

 

Oberon's founder James Hogan said:

"After 32 years it's time to ensure that Oberon and its authors achieve a secure, lively home in the future. I'm truly delighted that Bloomsbury, the leaders in drama publishing, are taking over to carry on the good work. I've spent nearly half of my life building Oberon's list and supporting new writers. It grew out of my work in a reading group at Riverside Studios in the early Eighties. I had little idea then that Oberon would flourish and become a major new force in the business. It's been a fantastic job working with so many brilliant authors and agents for so long."

 

-ENDS-

 

For further information, please contact:

Bloomsbury Publishing Plc

+44 (0) 20 7631 5630

Nigel Newton, Chief Executive

Penny Scott-Bayfield, Group Finance Director

Hudson Sandler

+44 (0) 20 7796 4133

Dan de Belder / Hattie Dreyfus

 

bloomsbury@hudsonsandler.com

 

NOTES TO EDITORS

 

Bloomsbury Publishing Plc

Bloomsbury Publishing Plc is a global independent publisher across trade, specialist, professional, school and higher education markets. Its Academic division has grown rapidly since its inception in 2008, publishing around 1200 titles per year and specialising in the arts, humanities and social sciences. It leads the field in innovative publishing, with a fast growing portfolio of digital resources, including the award-winning Drama Online.

 

The Methuen Drama imprint includes a diverse range of plays by authors including Sarah Kane, Katori Hall, Arthur Miller, Kwame Kwei-Armah, James Graham, Edward Bond, Lucy Prebble, Mark Ravenhill and Caryl Churchill. As well as play texts Methuen Drama publishes books for theatre-goers, students, scholars, practitioners, actors and those wishing to pursue a career in the theatre industry.

 

 

Oberon Books

Founded in 1985 by James Hogan, Oberon Books is now one of the most exciting publishers specialising in drama and the performing arts. It has a backlist of 1500+ books including some of the best of British theatre since the 1940s, diverse European and world theatre in translation and classics from the world's leading dramatists, and a wide range of publications covering the theatre, opera, dance, biography, performance studies, monologues, practical guides and fiction.

 

Oberon has a reputation for publishing some of the most challenging, exciting drama happening right now, bringing into print plays from the stages of the National Theatre, the Donmar Warehouse, the Royal Court, the Tricycle, Traverse, Soho, major regional theatres, and fringe theatres, not forgetting the West End and Broadway.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQCKKDQKBDDBBD
Date   Source Headline
16th Feb 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
14th Feb 20247:00 amRNSTrading Update
1st Feb 20243:11 pmRNSBloomsbury launches latest Sarah J. Maas novel
15th Jan 20247:00 amRNSBloomsbury Appoints Head of Investor Relations
12th Jan 202411:45 amRNSHolding(s) in Company
9th Jan 20244:10 pmRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSTrading Update
15th Nov 20237:00 amRNSBlocklisting Application
31st Oct 20237:00 amRNSInvestor Presentation
26th Oct 20237:00 amRNSUnaudited Interim Results
9th Oct 20231:00 pmRNSBloomsbury playwright Jon Fosse wins Nobel Prize
22nd Sep 20231:26 pmRNSDirector/PDMR Shareholdings - Correction
14th Sep 20237:00 amRNSBloomsbury launches new book by Katherine Rundell
5th Sep 20237:00 amRNSDirector/PDMR Shareholding
1st Sep 20232:05 pmRNSDirector/PDMR Shareholding
30th Aug 20231:56 pmRNSDirector/PDMR Shareholding
29th Aug 20232:11 pmRNSDirector/PDMR Shareholding
23rd Aug 20237:00 amRNSHolding(s) in Company
22nd Aug 20238:00 amRNSBloomsbury enjoys bestseller success
17th Aug 20234:40 pmRNSBLOCK LISTING SIX MONTHLY RETURN
18th Jul 20235:13 pmRNSResults of the 2023 Annual General Meeting
18th Jul 20237:00 amRNSAGM Trading Update
23rd Jun 20232:29 pmRNSAnnual Financial Report
2nd Jun 202311:50 amRNSDirector/PDMR Shareholding
1st Jun 20239:34 amRNSDirector Declaration
31st May 20232:04 pmRNSInvestor Presentation
31st May 20237:00 amRNSAudited Preliminary Results
16th May 20237:00 amRNSNotice of Capital Markets Event
2nd May 20232:43 pmRNSNotice of Results
12th Apr 20233:16 pmRNSHolding(s) in Company
11th Apr 202310:03 amRNSHolding(s) in Company
15th Mar 20237:00 amRNSTrading Update
1st Mar 20237:00 amRNSNotice of Trading Update
17th Feb 20232:09 pmRNSBLOCK LISTING SIX MONTHLY RETURN
11th Jan 20239:08 amRNSHolding(s) in Company
18th Nov 20222:29 pmRNSHolding(s) in Company
14th Nov 20225:16 pmRNSHolding(s) in Company
2nd Nov 20222:56 pmRNSDirector/PDMR Shareholding
1st Nov 20225:16 pmRNSHolding(s) in Company
31st Oct 20227:00 amRNSInvestor Presentation
27th Oct 20221:02 pmEQSBloomsbury Publishing pleased with 'surge in the numbers'
26th Oct 20227:00 amRNSUnaudited Interim Results
14th Oct 202212:41 pmRNSHolding(s) in Company
4th Oct 20224:40 pmRNSSecond Price Monitoring Extn
4th Oct 20224:36 pmRNSPrice Monitoring Extension
7th Sep 202211:16 amRNSHolding(s) in Company
24th Aug 20225:01 pmRNSDirector/PDMR Shareholding
22nd Aug 20224:16 pmRNSDirector/PDMR Shareholding
17th Aug 20227:00 amRNSBlock Listing Six Monthly Return
10th Aug 20225:22 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.